https://clinicaltrials.gov/ct2/show/NCT04353817?recrs=abdf
https://clinicaltrials.gov/ct2/show/NCT04353817?recrs=abdf&type=Intr&cond=Cystic+Fibrosis&lupd_s=04%2F06%2F2020&lupd_d=14
Condition : Cystic Fibrosis
Interventions : Drug: ELX/TEZ/IVA; Drug: IVA; Other: Placebo
Sponsor : Vertex Pharmaceuticals Incorporated
Not yet recruiting
A Study Evaluating Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis and F/MF Genotypes
NCT04353817
Mon, 20 Apr 2020 12:00:00 EDT
Last Update Posted: 04/20/20 07:17AM